Skip to content
PubMed This is a summary of 83 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 83 referenced papers

Top Authors

Michael F. Chiang
National Institutes of Health
M. Elizabeth Hartnett
Smith-Kettlewell Eye Research Institute
Andréa Zin
Universitätsmedizin Greifswald
Chiara Ionio
Università Cattolica del Sacro Cuore
Graham E. Quinn
University of Pennsylvania Health System
Gianluca Lista
Ospedale dei Bambini Vittore Buzzi
J. Peter Campbell
Oregon Health & Science University
Wei‐Chi Wu
Chang Gung University
George Ellis
Fundação Armando Alvares Penteado
Walter M. Fierson
Fundação Armando Alvares Penteado

Top Institutions

Ranked by publications Top 10 institutions
01

Oregon Health & Science University

Portland, United States

92 papers

References

References (83)
  1. 1

    Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone.

    Mueller B, Salchow DJ, Waffenschmidt E, et al.

    The British journal of ophthalmology 2017; (101(3)):365-370 doi:10.1136/bjophthalmol-2016-308375.

    PMID: 27301450
  2. 2

    OUTCOMES AFTER LASER VERSUS COMBINED LASER AND BEVACIZUMAB TREATMENT FOR TYPE 1 RETINOPATHY OF PREMATURITY IN ZONE I.

    Yoon JM, Shin DH, Kim SJ, et al.

    Retina (Philadelphia, Pa.) 2017; (37(1)):88-96 doi:10.1097/IAE.0000000000001125.

    PMID: 27347645
  3. 3

    Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone.

    Lux AL, Degoumois A, Barjol A, et al.

    Acta ophthalmologica 2017; (95(2)):165-169 doi:10.1111/aos.13175.

    PMID: 27519933
  4. 4

    Mothers and Fathers in NICU: The Impact of Preterm Birth on Parental Distress.

    Ionio C, Colombo C, Brazzoduro V, et al.

    Europe's journal of psychology 2016; (12(4)):604-621 doi:10.5964/ejop.v12i4.1093.

    PMID: 27872669
  5. 5

    Advances in understanding and management of retinopathy of prematurity.

    Hartnett ME

    Survey of ophthalmology 2017; (62(3)):257-276 doi:10.1016/j.survophthal.2016.12.004.

    PMID: 28012875
  6. 6

    Visual outcome and refractive status in first 3 years of age in preterm infants suffered from laser-treated Type 1 retinopathy of prematurity (ROP): a 6-year retrospective review in a tertiary centre in Hong Kong.

    Lok JYC, Yip WWK, Luk ASW, et al.

    International ophthalmology 2018; (38(1)):163-169 doi:10.1007/s10792-016-0439-5.

    PMID: 28054213
  7. 7

    Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children.

    Kabataş EU, Kurtul BE, Altıaylık Özer P, Kabataş N

    Current eye research 2017; (42(7)):1054-1058 doi:10.1080/02713683.2016.1264607.

    PMID: 28128986
  8. 8

    Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology.

    VanderVeen DK, Melia M, Yang MB, et al.

    Ophthalmology 2017; (124(5)):619-633 doi:10.1016/j.ophtha.2016.12.025.

    PMID: 28341474
  9. 9

    Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy.

    Wang H

    Eye and brain 2016; (8()):81-90 doi:10.2147/EB.S94449.

    PMID: 28539803
  10. 10

    Re: Screening for retinopathy of prematurity and treatment outcome in a tertiary hospital in Hong Kong.

    Chan KK, Lok JY, Yip WW, Young AL

    Hong Kong medical journal = Xianggang yi xue za zhi 2017; (23(3)):316 doi:10.12809/hkmj176306.

    PMID: 28572526
  11. 11

    Refractive and ocular biometric profile of children with a history of laser treatment for retinopathy of prematurity.

    Kaur S, Sukhija J, Katoch D, et al.

    Indian journal of ophthalmology 2017; (65(9)):835-840 doi:10.4103/ijo.IJO_872_16.

    PMID: 28905827
  12. 12

    Increased frequency of retinopathy of prematurity over the last decade and significant regional differences.

    Holmström G, Tornqvist K, Al-Hawasi A, et al.

    Acta ophthalmologica 2018; (96(2)):142-148 doi:10.1111/aos.13549.

    PMID: 29068172
  13. 13

    Oxygen, weight gain, IGF-1 and ROP: not a straight-forward equation.

    Darlow BA, Binenbaum G

    Acta paediatrica (Oslo, Norway : 1992) 2018; (107(5)):732-733 doi:10.1111/apa.14114.

    PMID: 29083092
  14. 14

    Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity.

    Kennedy KA, Mintz-Hittner HA,

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2018; (22(1)):61-65.e1 doi:10.1016/j.jaapos.2017.10.006.

    PMID: 29223789
  15. 15

    Glaucoma after Lens-Sparing Vitrectomy for Advanced Retinopathy of Prematurity.

    Nudleman E, Muftuoglu IK, Gaber R, et al.

    Ophthalmology 2018; (125(5)):671-675 doi:10.1016/j.ophtha.2017.11.009.

    PMID: 29241743
  16. 16

    Development of a scale for grading pre-plus and plus disease using retinal images: A pilot study.

    Nasrazadani DA, Wallace DK, Freedman SF, Prakalapakorn SG

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2018; (22(4)):316-319 doi:10.1016/j.jaapos.2018.01.007.

    PMID: 29630931
  17. 17

    A Qualitative Analysis of Challenges and Successes in Retinopathy of Prematurity Screening.

    Bain LC, Kristensen-Cabrera AI, Lee HC

    AJP reports 2018; (8(2)):e128-e133 doi:10.1055/s-0038-1660519.

    PMID: 29896443
  18. 18

    Spontaneous Attachment of Rhegmatogenous Retinal Detachment Following Vitrectomy for Stage 4B Retinopathy of Prematurity and Atypical Retinal Changes Post-Resolution.

    Savla LP, Nene A, Sutar S, Padhi TR

    Ophthalmic surgery, lasers & imaging retina 2018; (49(7)):544-547 doi:10.3928/23258160-20180628-13.

    PMID: 30021044
  19. 19

    Different effects of various anti-angiogenic treatments in an experimental mouse model of retinopathy of prematurity.

    Heiduschka P, Plagemann T, Li L, et al.

    Clinical & experimental ophthalmology 2019; (47(1)):79-87 doi:10.1111/ceo.13368.

    PMID: 30073769
  20. 20

    Late ROP Reactivation and Retinal Detachment in a Teenager.

    Golas L, Shapiro MJ, Blair MP

    Ophthalmic surgery, lasers & imaging retina 2018; (49(8)):625-628 doi:10.3928/23258160-20180803-11.

    PMID: 30114308
  21. 21

    Practical guidelines for screening and treatment of retinopathy of prematurity in Saudi Arabia.

    Al Amro SA, Al Aql F, Al Hajar S, et al.

    Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2018; (32(3)):222-226 doi:10.1016/j.sjopt.2018.07.007.

    PMID: 30224887
  22. 22

    The genetics of retinopathy of prematurity: a model for neovascular retinal disease.

    Swan R, Kim SJ, Campbell JP, et al.

    Ophthalmology. Retina 2018; (2(9)):949-962 doi:10.1016/j.oret.2018.01.016.

    PMID: 30250936
  23. 23

    Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.

    Quinn GE, Ying GS, Bell EF, et al.

    JAMA ophthalmology 2018; (136(12)):1383-1389 doi:10.1001/jamaophthalmol.2018.4290.

    PMID: 30326046
  24. 24

    Intravitreal Delivery of VEGF-A165-loaded PLGA Microparticles Reduces Retinal Vaso-Obliteration in an In Vivo Mouse Model of Retinopathy of Prematurity.

    Mezu-Ndubuisi OJ, Wang Y, Schoephoerster J, et al.

    Current eye research 2019; (44(3)):275-286 doi:10.1080/02713683.2018.1542736.

    PMID: 30383455
  25. 25

    Screening Examination of Premature Infants for Retinopathy of Prematurity.

    Fierson WM, , , et al.

    Pediatrics 2018; (142(6)) doi:10.1542/peds.2018-3061.

    PMID: 30478242
  26. 26

    Current concepts and techniques of vitrectomy for retinopathy of prematurity.

    Kusaka S

    Taiwan journal of ophthalmology 2018; (8(4)):216-221 doi:10.4103/tjo.tjo_102_18.

    PMID: 30637193
  27. 27

    Surgical outcomes of vitreoretinal surgery for rhegmatogenous retinal detachment in eyes with regressed retinopathy of prematurity.

    Sen P, Agarwal A, Bhende P, Gopal L

    Indian journal of ophthalmology 2019; (67(6)):896-902 doi:10.4103/ijo.IJO_706_18.

    PMID: 31124511
  28. 28

    Circumferential retinal hemorrhages after ophthalmic examination with scleral depression in an infant with anti-VEGF treated retinopathy of prematurity.

    Hussain RM, Tran KD, Prakhunghunsit S, et al.

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2019; (23(5)):293-295 doi:10.1016/j.jaapos.2019.05.002.

    PMID: 31145988
  29. 29

    Anti-vascular endothelial growth factor intravitreal therapy for retinopathy of prematurity.

    VanderVeen DK, Cataltepe SU

    Seminars in perinatology 2019; (43(6)):375-380 doi:10.1053/j.semperi.2019.05.011.

    PMID: 31174872
  30. 30

    Visual function is reduced in young adults formerly born prematurely: a population-based study.

    Pétursdóttir D, Holmström G, Larsson E

    The British journal of ophthalmology 2020; (104(4)):541-546 doi:10.1136/bjophthalmol-2019-314429.

    PMID: 31302630
  31. 31

    Efficiency and safety of phenylephrine and tropicamide used in premature retinopathy: a prospective observational study.

    Alpay A, Canturk Ugurbas S, Aydemir C

    BMC pediatrics 2019; (19(1)):415 doi:10.1186/s12887-019-1757-3.

    PMID: 31690284
  32. 32

    Intravitreal bevacizumab injection in aggressive posterior retinopathy of prematurity compared with type I retinopathy of prematurity.

    Eftekhari Milani A, Hassanpoor N, Mousavi Mirkala M, et al.

    International ophthalmology 2020; (40(2)):477-482 doi:10.1007/s10792-019-01208-3.

    PMID: 31712928
  33. 33

    Prevalence and Longevity of PTSD Symptoms Among Parents of NICU Infants Analyzed Across Gestational Age Categories.

    Schecter R, Pham T, Hua A, et al.

    Clinical pediatrics 2020; (59(2)):163-169 doi:10.1177/0009922819892046.

    PMID: 31833404
  34. 34

    Retinopathy of Prematurity: Evolving Treatment With Anti-Vascular Endothelial Growth Factor.

    Hartnett ME

    American journal of ophthalmology 2020; (218()):208-213 doi:10.1016/j.ajo.2020.05.025.

    PMID: 32450064
  35. 35

    A safety review of drugs used for the treatment of retinopathy of prematurity.

    Filippi L, Dal Monte M

    Expert opinion on drug safety 2020; (19(11)):1409-1418 doi:10.1080/14740338.2020.1826927.

    PMID: 32954858
  36. 36

    Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model.

    Zhang J, Zhu M, Ruan L, et al.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2020; (34(12)):15822-15836 doi:10.1096/fj.202001295R.

    PMID: 33103304
  37. 37

    Update on the Use of Anti-VEGF Drugs in the Treatment of Retinopathy of Prematurity.

    Seery CW, Betesh S, Guo S, et al.

    Journal of pediatric ophthalmology and strabismus 2020; (57(6)):351-362 doi:10.3928/01913913-20200824-02.

    PMID: 33211892
  38. 38

    Progression from preplus to plus disease in the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study: incidence, timing, and predictors.

    Cheng QE, Quinn GE, Daniel E, et al.

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2020; (24(6)):354.e1-354.e6 doi:10.1016/j.jaapos.2020.07.016.

    PMID: 33212296
  39. 39

    Commentary: Looking beyond anti-vascular endothelial growth factor - Novel therapeutic targets for retinopathy of prematurity.

    Dogra M, Singh SR

    Indian journal of ophthalmology 2021; (69(2)):374-375 doi:10.4103/ijo.IJO_3272_20.

    PMID: 33463596
  40. 40

    Aggressive posterior retinopathy of prematurity: a review on current understanding.

    Kumawat D, Sachan A, Shah P, et al.

    Eye (London, England) 2021; (35(4)):1140-1158 doi:10.1038/s41433-021-01392-6.

    PMID: 33514899
  41. 41

    Management of aggressive posterior retinopathy of prematurity in oculocutaneous albinism.

    Panchal B, Gulati M

    BMJ case reports 2021; (14(2)) doi:10.1136/bcr-2020-238490.

    PMID: 33526528
  42. 42

    Key factors in a rigorous longitudinal image-based assessment of retinopathy of prematurity.

    Rosenblatt TR, Ji MH, Vail D, et al.

    Scientific reports 2021; (11(1)):5369 doi:10.1038/s41598-021-84723-7.

    PMID: 33686091
  43. 43

    Laser photocoagulation for the treatment of bilateral late-onset retinopathy of prematurity-related retinal detachment in an adult male: A case report.

    Lin TY, Feng KM, Chang YH, Liang IC

    Medicine 2021; (100(22)):e26227 doi:10.1097/MD.0000000000026227.

    PMID: 34087903
  44. 44

    International Classification of Retinopathy of Prematurity, Third Edition.

    Chiang MF, Quinn GE, Fielder AR, et al.

    Ophthalmology 2021; (128(10)):e51-e68 doi:10.1016/j.ophtha.2021.05.031.

    PMID: 34247850
  45. 45

    Nigerian neonatologists perception and experience with retinopathy of prematurity.

    Adio A, Aliyu SS, Balarabe AH, et al.

    Journal of public health in Africa 2021; (12(1)):1289 doi:10.4081/jphia.2021.1289.

    PMID: 34267892
  46. 46

    Effect of Probenecid on Endothelial Cell Growth Rate and Retinal Angiogenesis in an Oxygen-Induced Retinopathy Model.

    Jiang J, Ou W, Luo X, et al.

    Frontiers in pharmacology 2021; (12()):717351 doi:10.3389/fphar.2021.717351.

    PMID: 34690760
  47. 47

    Avoiding use of lid speculum and indentation reduced infantile stress during retinopathy of prematurity examinations.

    Mataftsi A, Lithoxopoulou M, Seliniotaki AK, et al.

    Acta ophthalmologica 2022; (100(1)):e128-e134 doi:10.1111/aos.15085.

    PMID: 34939742
  48. 48

    Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity.

    Ramshekar A, Hartnett ME

    Frontiers in pediatrics 2021; (9()):796143 doi:10.3389/fped.2021.796143.

    PMID: 34956992
  49. 49

    Frequency of retinopathy of prematurity (ROP) in infants screened for ROP: two years follow-up results of a single center in Turkey.

    Ugurlu A

    BioMedicine 2021; (11(3)):38-42 doi:10.37796/2211-8039.1188.

    PMID: 35223409
  50. 50

    Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.

    Kondo C, Iwahashi C, Utamura S, et al.

    Frontiers in pediatrics 2022; (10()):785292 doi:10.3389/fped.2022.785292.

    PMID: 35463897
  51. 51

    Analgesia for retinopathy of prematurity screening: A systematic review.

    Thirunavukarasu AJ, Hassan R, Savant SV, Hamilton DL

    Pain practice : the official journal of World Institute of Pain 2022; (22(7)):642-651 doi:10.1111/papr.13138.

    PMID: 35703418
  52. 52

    STRUCTURAL OUTCOME AFTER SURGERY FOR STAGE 5 RETINOPATHY OF PREMATURITY BASED ON THE NEW INTERNATIONAL CLASSIFICATION: ICROP 3.

    Mano F, Iwahashi C, Kuniyoshi K, Kusaka S

    Retina (Philadelphia, Pa.) 2022; (42(10)):1950-1957 doi:10.1097/IAE.0000000000003541.

    PMID: 35963009
  53. 53

    Retinopathy of Prematurity in the University of Calabar Teaching Hospital, Calabar, Nigeria: An Early Report of a Screening Service.

    Nkanga ED, Agweye CT, Etim BA, et al.

    Journal of the West African College of Surgeons 2021; (11(3)):6-12 doi:10.4103/jwas.jwas_62_21.

    PMID: 36132975
  54. 54

    Late sequelae of retinopathy of prematurity in adolescence and adulthood.

    Özdemir HB, Özdek S

    Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2022; (36(3)):270-277 doi:10.4103/sjopt.sjopt_276_21.

    PMID: 36276258
  55. 55

    Clinical feature and predictive factor analysis for spontaneous regression of retinopathy of prematurity in a Chinese population.

    Li YA, Zhou XH, Cai XJ, Yang CH

    International journal of ophthalmology 2022; (15(12)):1978-1984 doi:10.18240/ijo.2022.12.13.

    PMID: 36536972
  56. 56

    The Prevalence of PTSD of Mothers and Fathers of High-Risk Infants Admitted to NICU: A Systematic Review.

    McKeown L, Burke K, Cobham VE, et al.

    Clinical child and family psychology review 2023; (26(1)):33-49 doi:10.1007/s10567-022-00421-4.

    PMID: 36564614
  57. 57

    Retinopathy of Prematurity in the 21st Century and the Complex Impact of Supplemental Oxygen.

    Rodriguez SH, Ells AL, Blair MP, et al.

    Journal of clinical medicine 2023; (12(3)) doi:10.3390/jcm12031228.

    PMID: 36769876
  58. 58

    Validation of the postnatal growth and retinopathy of prematurity (G-ROP) screening criteria in a Thai cohort.

    Trinavarat A, Najmuangchan N, Ngerncham S, et al.

    Japanese journal of ophthalmology 2023; (67(4)):387-395 doi:10.1007/s10384-023-01003-9.

    PMID: 37341847
  59. 59

    Reactivation of retinopathy of prematurity six years after intravitreal injection of bevacizumab.

    Yasin A, Sinha S, Smith R, et al.

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2023; (27(4)):236-239 doi:10.1016/j.jaapos.2023.05.008.

    PMID: 37451499
  60. 60

    Prevalence of anxiety, depression, and stress among parents of neonates admitted to neonatal intensive care unit: a systematic review and meta-analysis.

    Shetty AP, Halemani K, Issac A, et al.

    Clinical and experimental pediatrics 2024; (67(2)):104-115 doi:10.3345/cep.2023.00486.

    PMID: 37986569
  61. 61

    FIVE-YEAR VISUAL OUTCOME OF TREATMENT FOR RETINOPATHY OF PREMATURITY IN INFANTS WEIGHING <500 G AT BIRTH: A Multicenter Cohort Study From J-CREST.

    Tomioka M, Murakami T, Okamoto F, et al.

    Retina (Philadelphia, Pa.) 2024; (44(4)):652-658 doi:10.1097/IAE.0000000000004016.

    PMID: 38064668
  62. 62

    Long-Term Visual Outcomes in Prematurely Born Children.

    Robitaille JM

    Journal of binocular vision and ocular motility 2024; (74(1)):1-8.

    PMID: 38078812
  63. 63

    Ophthalmic sequelae of prematurity in late childhood and adulthood: A review.

    Downes RA, Rachitskaya AV

    Clinical & experimental ophthalmology 2024; (52(3)):355-364 doi:10.1111/ceo.14358.

    PMID: 38334000
  64. 64

    Effects of web neonatal intensive care unit diaries on the mental health, quality of life, sleep quality, care ability, and hormone levels of parents of preterm infants in the neonatal intensive care unit: A randomized controlled trial.

    Li X, Lin Y, Huang L, et al.

    Intensive & critical care nursing 2024; (83()):103697 doi:10.1016/j.iccn.2024.103697.

    PMID: 38583413
  65. 65

    A Study of the Demographic Profile, Screening, and Management of Patients Visiting a Retinopathy of Prematurity Clinic.

    Mushtaq I, Agrawal T, Bhavsar D, et al.

    Cureus 2024; (16(4)):e58305 doi:10.7759/cureus.58305.

    PMID: 38752079
  66. 66

    [Interpretation of the UK screening and treatment of retinopathy of prematurity updated 2022 guidelines].

    Dong XY, Li JZ, Luo KR, et al.

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2024; (26(5)):437-443 doi:10.7499/j.issn.1008-8830.2311073.

    PMID: 38802901
  67. 67

    Incidence, Risk Factors and Development of Retinopathy of Prematurity in Mid-Preterm and Late-Preterm Infants.

    Yenice EK, Kara C, Kavurt AS, Işleyen F

    Journal of pediatric ophthalmology and strabismus 2024; (61(5)):351-357 doi:10.3928/01913913-20240508-05.

    PMID: 38815107
  68. 68

    Intranasal dexmedetomidine reduces pain scores in preterm infants during retinopathy of prematurity screening.

    Ozkan Zarif N, Arayici S, Celik K, et al.

    Frontiers in pediatrics 2024; (12()):1441324 doi:10.3389/fped.2024.1441324.

    PMID: 39156022
  69. 69

    Long-term follow-up after lens-sparing vitrectomy for complications of retinopathy of prematurity.

    Gopal L, Bhende P, Rao C, et al.

    Indian journal of ophthalmology 2025; (73(Suppl 1)):S132-S138 doi:10.4103/IJO.IJO_179_24.

    PMID: 39257102
  70. 70

    Preferred Treatment Patterns of Retinopathy of Prematurity: An International Survey.

    Wang AT, Dai S

    Pediatric reports 2024; (16(3)):816-822 doi:10.3390/pediatric16030069.

    PMID: 39311332
  71. 71

    [National protocol for diagnosis and care of retinopathy of prematurity: Summary for the attending physician].

    Daruich A, Bremond-Gignac D, Aziz A, et al.

    Journal francais d'ophtalmologie 2025; (48(1)):104333 doi:10.1016/j.jfo.2024.104333.

    PMID: 39454240
  72. 72

    Recurrence of Retinopathy of Prematurity Following Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy: A Systematic Review and Meta-Analysis.

    Dablouk M, Chhabra A, Masoud AT

    Cureus 2024; (16(11)):e73286 doi:10.7759/cureus.73286.

    PMID: 39524166
  73. 73

    Quantitative comparison of vascular characteristics of plus disease images published over time: International Classification of Retinopathy of Prematurity.

    Wang W, Freedman SF, Wallace DK, Prakalapakorn SG

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2025; (29(1)):104101 doi:10.1016/j.jaapos.2024.104101.

    PMID: 39746533
  74. 74

    A Meta-Analysis of Intravitreal Ranibizumab versus Laser Photocoagulation for the Treatment of Retinopathy of Prematurity.

    Baiad AA, Sun C, Yin GS, et al.

    Ophthalmology. Retina 2025; (9(7)):677-689 doi:10.1016/j.oret.2025.01.012.

    PMID: 39842716
  75. 75

    Establishing an objective quantitative method for assessing the severity of plus disease in retinopathy of prematurity.

    Maitra P, Kang EY, Wu WC

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2025; (263(4)):985-992 doi:10.1007/s00417-025-06743-7.

    PMID: 39870912
  76. 76

    Knowledge, Attitudes and Practices of Health Workers and Caregivers Towards Retinopathy of Prematurity in Uganda: A Mixed-Methods Study.

    Lusobya RC, Atukunda I, Semulimi AW, et al.

    Public health challenges 2024; (3(3)):e208 doi:10.1002/puh2.208.

    PMID: 40496533
  77. 77

    A Comparative Analysis of Anxiety, Depression, and Hopelessness Levels in Parents After Retinopathy of Prematurity Examination.

    Akyuz Unsal AI, Bekmez S, Aydin Eroglu S, et al.

    Journal of pediatric ophthalmology and strabismus 2025; 1-8 doi:10.3928/01913913-20250530-06.

    PMID: 40736050
  78. 78

    Epidemiological Profile of Retinopathy of Prematurity in Central India.

    Joshi RS, Singh H, Joshi R, et al.

    Cureus 2025; (17(7)):e87259 doi:10.7759/cureus.87259.

    PMID: 40761957
  79. 79

    Effect of Ranibizumab in Patients with Treatment-Naïve Retinopathy of Prematurity.

    Khalid H, Malik TG, Amjad A, et al.

    Turkish journal of ophthalmology 2025; (55(4)):200-206 doi:10.4274/tjo.galenos.2025.77992.

    PMID: 40838511
  80. 80

    Caregiver Impact and Understanding of Retinopathy of Prematurity Screening.

    Song W, Hui M, Khitri M, et al.

    Journal of patient experience 2025; (12()):23743735251383261 doi:10.1177/23743735251383261.

    PMID: 41049119
  81. 81

    Factors influencing the timing of complete retinal vascularization in infants screened for retinopathy of prematurity.

    Kuziel J, Strampe M, VandeLune J, et al.

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2025; (29(6)):104659 doi:10.1016/j.jaapos.2025.104659.

    PMID: 41067499
  82. 82

    Prevalence of strabismus, nystagmus and risk factors in children and adolescents born preterm with and without retinopathy of prematurity: results from the Gutenberg Prematurity Study Young.

    Fieß A, Gißler S, Hartmann A, et al.

    The British journal of ophthalmology 2026; (110(4)):370-378 doi:10.1136/bjo-2025-327571.

    PMID: 41072940
  83. 83

    Long-term results of surgery for retinal detachment due to retinopathy of prematurity.

    Joshi A, Chawla A, Valakkadavil H, et al.

    Indian journal of ophthalmology 2025; (73(11)):1670-1674 doi:10.4103/IJO.IJO_1414_25.

    PMID: 41148021